Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sumkauskaite

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Der Radiologe|June 12, 2015
[Drug therapy in interventional radiology]M Sumkauskaite, M Bryant, N Kortes, et al.
Der Radiologe|February 18, 2016
[Subintimal recanalization. Indications, technique and results]B Radeleff, M Sumkauskaite, N Kortes, et al.
Physics in Medicine and Biology|August 3, 2012
Statistical tracking of tree-like tubular structures with efficient branching detection in 3D medical image dataX Wang, T Heimann, P Lo, et al.
European Radiology|November 1, 2014
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are takenJ Hillengass, J Stoll, C M Zechmann, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Der Radiologe|June 12, 2015
[Drug therapy in interventional radiology]M Sumkauskaite, M Bryant, N Kortes, et al.
Der Radiologe|February 18, 2016
[Subintimal recanalization. Indications, technique and results]B Radeleff, M Sumkauskaite, N Kortes, et al.
Physics in Medicine and Biology|August 3, 2012
Statistical tracking of tree-like tubular structures with efficient branching detection in 3D medical image dataX Wang, T Heimann, P Lo, et al.
European Radiology|November 1, 2014
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are takenJ Hillengass, J Stoll, C M Zechmann, et al.
Pageof 1